articleTop 1% cited
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
The Lancet Oncology · 2008 · Vol. 10(1) · pp. 25–34
Ann‐Lii Cheng✉(National Taiwan University Hospital)Yoon‐Koo Kang(Asan Medical Center)Zhendong Chen(First Affiliated Hospital of Anhui Medical University)Chao-Jung Tsao(Chi Mei Medical Center)Shukui Qin(81th Hospital of PLA)Jun Suk Kim(Korea University Medical Center)Rongcheng Luo(Nanfang Hospital)Jifeng Feng(Jiangsu Cancer Hospital)Sheng‐Long Ye(Sun Yat-sen University)Tsai‐Sheng Yang(Chang Gung Memorial Hospital)Jianming Xu(Academy of Military Medical Sciences)Yan Sun(Chinese Academy of Medical Sciences & Peking Union Medical College)Houjie Liang(Southwest Hospital)Jiwei Liu(Dalian Medical University)Jiejun Wang(Shanghai Changzheng Hospital)Won Young Tak(Kyungpook National University Hospital)Hongming Pan(Sir Run Run Shaw Hospital)K. Burock(Bayer (Germany))J. Zou(Bayer (China))D. Voliotis(Bayer (United States))Zhongzhen Guan(Sun Yat-sen University Cancer Center)
Hepatocellular Carcinoma Treatment and PrognosisCancer Mechanisms and TherapyLiver physiology and pathologySorafenibHepatocellular carcinomaPlaceboMedicineDouble blindInternal medicinePhase (matter)OncologyAlternative medicinePathology
MeSH terms
SorafenibAdultAgedAged, 80 and overAntineoplastic AgentsBenzenesulfonatesCost-Benefit AnalysisDouble-Blind MethodFemaleCarcinoma, HepatocellularHumansLiver NeoplasmsMaleMiddle AgedNiacinamide
Funding
- Bayer HealthCare
Citations
5,801
FWCI
85.25
field-weighted impact
References
42
Percentile
100%
vs. same field & year
Citations per year
Cited by
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Hepatology · 2018 · 4,515 citations
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Journal of Hepatology · 2018 · 11,335 citations
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Hepatology · 2023 · 1,480 citations
AASLD guidelines for the treatment of hepatocellular carcinoma
Hepatology · 2017 · 4,115 citations
Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
Cancers · 2020 · 318 citations
The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
BioMed Research International · 2012 · 396 citations
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Journal of Cancer · 2012 · 1,107 citations
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Cells · 2020 · 489 citations
References
Sorafenib in Advanced Hepatocellular Carcinoma
New England Journal of Medicine · 2008 · 12,835 citations
Transection of the oesophagus for bleeding oesophageal varices
British journal of surgery · 1973 · 7,910 citations
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Nature Reviews Drug Discovery · 2006 · 1,812 citations
Global cancer statistics in the year 2000
The Lancet Oncology · 2001 · 2,455 citations
What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?
Medical Care · 2008 · 585 citations
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
Gastroenterology · 2007 · 5,410 citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
JNCI Journal of the National Cancer Institute · 2000 · 15,689 citations
Natural History of Untreated Nonsurgical Hepatocellular Carcinoma: Rationale for the Design and Evaluation of Therapeutic Trials
Hepatology · 1999 · 1,197 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.